| Overall (N = 1193) | Current smoking in males (N = 624) | Current smoking in females (N = 569) | ||||
---|---|---|---|---|---|---|---|
No (N = 260) | Yes (N = 364) | p value | No (N = 260) | Yes (N = 364) | p value | ||
Number of psychiatric disorders | |||||||
 One | 1079 (90.4%) | 233 (41.5%) | 329 (58.5%) | 0.751 | 481 (93.0%) | 36 (7.0%) | 0.391 |
 Two or more | 114 (9.6%) | 27 (43.5%) | 35 (56.5%) |  | 50 (96.2%) | 2 (3.8%) |  |
Psychiatric disorders | |||||||
 Primary psychotic disorders | 491 (41.2%) | 119 (36.3%) | 209 (63.7%) | 0.004 | 143 (87.7%) | 20 (12.3%) | 0.001 |
 Primary bipolar disorders | 183 (15.3%) | 29 (41.4%) | 41 (58.6%) | 0.966 | 106 (93.8%) | 7 (6.2%) | 0.818 |
 Primary depressive disorders | 200 (16.8%) | 37 (59.7%) | 25 (40.3%) | 0.002 | 132 (95.7%) | 6 (4.3%) | 0.208 |
 Primary anxiety disorders | 131 (11.0%) | 32 (54.2%) | 27 (45.8%) | 0.040 | 72 (100.0%) | 0 (0.0%) | 0.009 |
 Personality disorders | 18 (1.5%) | 1 (12.5%) | 7 (87.5%) | 0.148 | 10 (100.0%) | 0 (0.0%) | > 0.95 |
 Secondary psychiatric disorders | 44 (3.7%) | 12 (33.3%) | 24 (66.7%) | 0.296 | 5 (62.5%) | 3 (37.5%) | 0.012 |
 Multiple disorders | 80 (6.7%) | 15 (35.7%) | 27 (64.3%) | 0.418 | 36 (94.7%) | 2 (5.3%) | > 0.95 |
 Other disorders | 46 (3.9%) | 15 (78.9%) | 4 (21.1%) | 0.001 | 27 (100.0%) | 0 (0.0%) | 0.245 |
Number of psychotropic medications | |||||||
 One | 363 (33.5%) | 97 (47.8%) | 106 (52.2%) | 0.004 | 148 (92.5%) | 12 (7.5%) | 0.497 |
 Two or more | 719 (66.5%) | 129 (35.4%) | 235 (64.6%) |  | 334 (94.1%) | 21 (5.9%) |  |
Psychotropic medications | |||||||
 Any antipsychotic | 830 (76.7%) | 164 (35.9%) | 293 (64.1%) | < 0.001 | 342 (91.7%) | 31 (8.3%) | 0.004 |
 First generation, low potency | 59 (5.5%) | 11 (42.3%) | 15 (57.7%) | 0.794 | 32 (97.0%) | 1 (3.0%) | 0.713 |
 First generation, high potency | 177 (16.4%) | 44 (41.9%) | 61 (58.1%) | 0.635 | 66 (91.7%) | 6 (8.3%) | 0.440 |
 Second generation | 733 (67.7%) | 147 (35.7%) | 265 (64.3%) | 0.001 | 292 (91.0%) | 29 (9.0%) | 0.002 |
 Any antidepressant | 450 (41.6%) | 93 (46.3%) | 108 (53.7%) | 0.021 | 240 (96.4%) | 9 (3.6%) | 0.012 |
 SSRI antidepressants | 312 (28.8%) | 63 (50.4%) | 62 (49.6%) | 0.006 | 180 (96.3%) | 7 (3.7%) | 0.062 |
 Tricyclic antidepressants | 69 (6.4%) | 10 (47.6%) | 11 (52.4%) | 0.459 | 45 (93.8%) | 3 (6.3%) | > 0.95 |
 Other antidepressants | 158 (14.6%) | 28 (32.6%) | 58 (67.4%) | 0.133 | 70 (97.2%) | 2 (2.8%) | 0.133 |
 Mood stabilizers | 301 (27.8%) | 59 (38.6%) | 94 (61.4%) | 0.701 | 140 (94.6%) | 8 (5.4%) | 0.555 |
 Antianxiety | 68 (6.3%) | 8 (29.6%) | 19 (70.4%) | 0.266 | 39 (95.1%) | 2 (4.9%) | > 0.95 |